BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lowe MN, Lamb HM. Meropenem: an updated review of its use in the management of intra-abdominal infections. Drugs 2000;60:619-46. [PMID: 11030471 DOI: 10.2165/00003495-200060030-00010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mazzei T, Novelli A. Pharmacological Rationale for Antibiotic Treatment of Intra-abdominal Infections. Journal of Chemotherapy 2013;21:19-29. [DOI: 10.1179/joc.2009.21.supplement-1.19] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Linden P. Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem. Drug Saf 2007;30:657-68. [PMID: 17696578 DOI: 10.2165/00002018-200730080-00002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
3 Cinar E, Ateskan U, Baysan A, Mas MR, Comert B, Yasar M, Ozyurt M, Yener N, Mas N, Ozkomur E, Altinatmaz K. Is late antibiotic prophylaxis effective in the prevention of secondary pancreatic infection? Pancreatology 2003;3:383-8. [DOI: 10.1159/000073653] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
4 Zhao W, Leroux S, Jacqz-Aigrain E. Dosage individualization in children: integration of pharmacometrics in clinical practice. World J Pediatr 2014;10:197-203. [PMID: 25124969 DOI: 10.1007/s12519-014-0493-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
5 Keam SJ. Doripenem: A Review of its Use in the Treatment of Bacterial Infections. Drugs 2008;68:2021-57. [DOI: 10.2165/00003495-200868140-00007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
6 Tellado JM, Wilson SE. Empiric Treatment of Nosocomial Intra-Abdominal Infections: A Focus on the Carbapenems. Surgical Infections 2005;6:329-43. [DOI: 10.1089/sur.2005.6.329] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
7 Cohen-Wolkowiez M, Poindexter B, Bidegain M, Weitkamp JH, Schelonka RL, Randolph DA, Ward RM, Wade K, Valencia G, Burchfield D, Arrieta A, Mehta V, Walsh M, Kantak A, Rasmussen M, Sullivan JE, Finer N, Rich W, Brozanski BS, van den Anker J, Blumer J, Laughon M, Watt KM, Kearns GL, Capparelli EV, Martz K, Berezny K, Benjamin DK Jr, Smith PB; Meropenem Study Team. Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections. Clin Infect Dis 2012;55:1495-502. [PMID: 22955430 DOI: 10.1093/cid/cis758] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
8 Baldwin CM, Lyseng-Williamson KA, Keam SJ. Meropenem: a review of its use in the treatment of serious bacterial infections. Drugs 2008;68:803-38. [PMID: 18416587 DOI: 10.2165/00003495-200868060-00006] [Cited by in Crossref: 104] [Cited by in F6Publishing: 83] [Article Influence: 7.4] [Reference Citation Analysis]
9 Coban A, Bilgin K, Tasdelen Fisgin N, Uzun M, Durupinar B. Effect of Meropenem against Multidrug-Resistant Mycobacterium tuberculosis. Journal of Chemotherapy 2013;20:395-6. [DOI: 10.1179/joc.2008.20.3.395] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
10 Kim SW, Jin JH, Kang SJ, Jung SI, Kim YS, Kim CK, Lee H, Oh WS, Kim S, Peck KR, Song JH. Therapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitis. J Korean Med Sci 2004;19:21-6. [PMID: 14966336 DOI: 10.3346/jkms.2004.19.1.21] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
11 Mazuski JE, Sawyer RG, Nathens AB, Dipiro JT, Schein M, Kudsk KA, Yowler C. The Surgical Infection Society Guidelines on Antimicrobial Therapy for Intra-Abdominal Infections: Evidence for the Recommendations. Surgical Infections 2002;3:175-233. [DOI: 10.1089/109629602761624180] [Cited by in Crossref: 99] [Cited by in F6Publishing: 73] [Article Influence: 5.0] [Reference Citation Analysis]
12 Yamada M, Watanabe T, Baba N, Takeuchi Y, Ohsawa F, Gomi S. Crystal structures of biapenem and tebipenem complexed with penicillin-binding proteins 2X and 1A from Streptococcus pneumoniae. Antimicrob Agents Chemother 2008;52:2053-60. [PMID: 18391040 DOI: 10.1128/AAC.01456-07] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
13 Unal S, Masterton R, Goossens H. Bacteraemia in Europe—antimicrobial susceptibility data from the MYSTIC surveillance programme. International Journal of Antimicrobial Agents 2004;23:155-63. [DOI: 10.1016/j.ijantimicag.2003.07.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
14 Chang Y, Chou M, Lin M, Chen C, Tsai T. Determination and pharmacokinetic study of meropenem in rat bile using on-line microdialysis and liquid chromatography. Journal of Chromatography A 2002;961:119-24. [DOI: 10.1016/s0021-9673(02)00078-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Knapp KM, English B. Carbapenems. Seminars in Pediatric Infectious Diseases 2001;12:175-85. [DOI: 10.1053/spid.2001.24093] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
16 Li C, Du X, Kuti JL, Nicolau DP. Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections. Antimicrob Agents Chemother 2007;51:1725-30. [PMID: 17307978 DOI: 10.1128/AAC.00294-06] [Cited by in Crossref: 179] [Cited by in F6Publishing: 75] [Article Influence: 11.9] [Reference Citation Analysis]
17 Lee JH, Lee DH, Kim JS, Jung WB, Heo W, Kim YK, Kim SH, No TH, Jo KM, Ko J, Lee HY, Jun KR, Choi HS, Jang JH, Jang HJ. Pharmacokinetics and Monte Carlo Simulation of Meropenem in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation. Front Pharmacol 2021;12:768912. [PMID: 34790131 DOI: 10.3389/fphar.2021.768912] [Reference Citation Analysis]
18 Curran M, Simpson D, Perry C. Ertapenem: a review of its use in the management of bacterial infections. Drugs 2003;63:1855-78. [PMID: 12921489 DOI: 10.2165/00003495-200363170-00006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]